How big is SunOpta, Inc.?

As of Jun 18, SunOpta, Inc. has a market capitalization of 678.22 million, with net sales of 742.52 million and a net profit of -10.50 million over the latest four quarters.

Market Cap: As of Jun 18, SunOpta, Inc. has a market capitalization of 678.22 million, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, SunOpta, Inc. reported net sales of 742.52 million and a net profit of -10.50 million.<BR><BR>Balance Sheet Snapshot: As of Dec'24, the company reported shareholder's funds of 163.64 million and total assets of 668.53 million.

What does SunOpta, Inc. do?

SunOpta, Inc. manufactures plant-based and fruit-based food and beverage products, operating in the FMCG industry with a market cap of approximately $678.22 million. As of March 2025, it reported net sales of $202 million and a net profit of $5 million.

Overview: <BR>SunOpta, Inc. is focused on the manufacturing of plant-based and fruit-based food and beverage products and operates in the FMCG industry with a micro-cap market classification.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 202 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 5 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 678.22 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 81.00 <BR>Dividend Yield: 0.00% <BR>Debt Equity: 1.68 <BR>Return on Equity: 4.87% <BR>Price to Book: 3.99<BR><BR>Contact Details: <BR>Address: 2233 Argentia Rd Suite 401, MISSISSAUGA ON: L5N 2X7 <BR>Tel: 1 905 4551990 <BR>Fax: 1 905 8219669 <BR>Website: http://www.sunopta.com

Who are in the management team of SunOpta, Inc.?

As of March 2022, the management team of SunOpta, Inc. includes R. Dean Hollis (Independent Chairman), Joseph Ennen (CEO), and several Independent Directors: Albert Bolles, Derek Briffett, Rebecca Fisher, Katrina Houde, and Leslie Keating. They oversee the company's operations and strategic direction.

As of March 2022, the management team of SunOpta, Inc. includes the following individuals:<BR><BR>- Mr. R. Dean Hollis, Independent Chairman of the Board<BR>- Mr. Joseph Ennen, Chief Executive Officer and Director<BR>- Dr. Albert Bolles, Independent Director<BR>- Mr. Derek Briffett, Independent Director<BR>- Ms. Rebecca Fisher, Independent Director<BR>- Ms. Katrina Houde, Independent Director<BR>- Ms. Leslie Keating, Independent Director<BR><BR>This team is responsible for overseeing the company's operations and strategic direction.

Should I buy, sell or hold SunOpta, Inc.?

Is SunOpta, Inc. technically bullish or bearish?

As of October 3, 2025, SunOpta, Inc. shows a neutral technical stance with mixed signals, including a mildly bearish weekly MACD and a mildly bullish monthly MACD, while underperforming the S&P 500 with a year-to-date return of -23.25%.

As of 3 October 2025, the technical trend for SunOpta, Inc. has changed from mildly bearish to sideways. The weekly MACD indicates a mildly bearish stance, while the monthly MACD shows a mildly bullish signal. The Bollinger Bands are bearish on the weekly and mildly bearish on the monthly, and the KST is mildly bearish weekly and bearish monthly. The daily moving averages are mildly bullish, and Dow Theory indicates a mildly bullish stance on the monthly timeframe. <BR><BR>In terms of performance, SunOpta has underperformed the S&P 500 across multiple periods, with a year-to-date return of -23.25% compared to the S&P's 14.18%, and a 3-year return of -38.76% versus the S&P's 82.57%. Overall, the current technical stance is neutral, reflecting mixed signals across different indicators.

Is SunOpta, Inc. overvalued or undervalued?

As of November 21, 2025, SunOpta, Inc. is considered overvalued with a P/E ratio of 81 and a year-to-date return of -56.49%, significantly underperforming compared to industry peers and the S&P 500.

As of 21 November 2025, the valuation grade for SunOpta, Inc. has moved from attractive to expensive, indicating a shift towards overvaluation. The company is currently assessed as overvalued, with a P/E ratio of 81, a Price to Book Value of 3.94, and an EV to EBITDA of 12.92. In comparison, peers like John B. Sanfilippo & Son, Inc. exhibit a much lower P/E of 12.73 and an EV to EBITDA of 7.10, highlighting the disparity in valuation metrics within the industry.<BR><BR>Additionally, SunOpta's recent stock performance has been significantly underwhelming, with a year-to-date return of -56.49% compared to a positive 12.26% return for the S&P 500, further reinforcing the notion of overvaluation. The company's ROCE stands at 7.97% and ROE at 4.87%, which are relatively low compared to industry expectations, suggesting that the current valuation may not be justified by its financial performance.